The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Cell Line, 2006Improving the Long-term Survival & Functionality of the Transplanted Human Dopaminergic Neurons Through Space Creation Strategy
Dr. Xuejun Wen was awarded a one-year award in 2004 as part of the MJFF Cell Line II program. Dr. Wen proposed to test a novel biodegradable ‘spacer’ device to improve embryonic stem (ES) cell-derived...
-
Molecular Mechanisms of Dyskinesia in Parkinson's Disease, 2005Mechanisms of Graft-Induced Dyskinesias in an Animal Model of Parkinson's Disease (Supplemental Funding)
Our ongoing project has four aims:
- To develop a model of graft-induced dyskinesia (GID) in the rat, which will provide a cost-effective tool for studying the mechanisms of this complication;
- To...
-
Rapid Response Innovation Awards, 2007Gene-Environment Interactions in Parkinson's Disease
Objective/Rationale:
Although the causes of sporadic Parkinson’s disease are still unknown, recent evidence suggests that exposure to pesticides increases the risk for PD. However, most of these... -
Rapid Response Innovation Awards, 2007Everyday Action Impairment in People with Parkinson's Disease Dementia/Dementia with Lewy Bodies
Objective/Rationale:
Parkinson’s disease (PD) and Parkinson’s Disease Dementia/Dementia with Lewy Bodies (PDD/DLB) have been associated with cognitive deficits and everyday action impairment (EAI; e.g... -
Rapid Response Innovation Awards, 2007Ethics of Sham Surgery Controls to Test Novel Parkinson's Disease Interventions
Objective/Rationale:
When experimental treatments involve neurosurgery, researchers often use a placebo condition called sham surgery, which involves an invasive procedure (e.g., partial thickness... -
Rapid Response Innovation Awards, 2007Re-distribution of Brain Gangliosides for Treatment of Parkinson's Disease
Project Description:
A pre-clinical model of Parkinson's disease can be generated by injecting MPTP, a toxin that results in specific damage to the same part of the brain that is damaged in Parkinson's...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.